BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15072488)

  • 1. Prognostic significance of a grading system considering tumor heterogeneity in muscle-invasive urothelial carcinoma of the urinary bladder.
    Krüger S; Thorns C; Böhle A; Feller AC
    Int Urol Nephrol; 2003; 35(2):169-73. PubMed ID: 15072488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases.
    Pan CC; Chang YH; Chen KK; Yu HJ; Sun CH; Ho DM
    Am J Clin Pathol; 2010 May; 133(5):788-95. PubMed ID: 20395527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2: Grading of Mixed Grade, Invasive Urothelial Carcinoma Including Histologic Subtypes and Divergent Differentiations, and Non-Urothelial Carcinomas.
    Paner GP; Kamat A; Netto GJ; Samaratunga H; Varma M; Bubendorf L; van der Kwast TH; Cheng L;
    Am J Surg Pathol; 2024 Jan; 48(1):e11-e23. PubMed ID: 37382156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma.
    Cheng L; Neumann RM; Nehra A; Spotts BE; Weaver AL; Bostwick DG
    Cancer; 2000 Apr; 88(7):1663-70. PubMed ID: 10738225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems.
    Oosterhuis JW; Schapers RF; Janssen-Heijnen ML; Pauwels RP; Newling DW; ten Kate F
    J Clin Pathol; 2002 Dec; 55(12):900-5. PubMed ID: 12461053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic tumor growth pattern is significantly associated with disease-related survival in muscle-invasive transitional cell carcinoma of the urinary bladder.
    Krüger S; Noack F; Böhle A; Feller AC
    Oncol Rep; 2004 Sep; 12(3):609-13. PubMed ID: 15289845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-grade papillary urothelial carcinoma of the urinary bladder: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center.
    Miyamoto H; Brimo F; Schultz L; Ye H; Miller JS; Fajardo DA; Lee TK; Epstein JI; Netto GJ
    Arch Pathol Lab Med; 2010 Aug; 134(8):1160-3. PubMed ID: 20670136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of Her2/neu overexpression in patients with muscle invasive urinary bladder cancer treated with radical cystectomy.
    Kolla SB; Seth A; Singh MK; Gupta NP; Hemal AK; Dogra PN; Kumar R
    Int Urol Nephrol; 2008; 40(2):321-7. PubMed ID: 17899426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour front inflammation and necrosis are independent prognostic predictors in high-grade urothelial carcinoma of the bladder.
    Hodgson A; Xu B; Satkunasivam R; Downes MR
    J Clin Pathol; 2018 Feb; 71(2):154-160. PubMed ID: 28768702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?
    Hentschel AE; van Rhijn BWG; Bründl J; Compérat EM; Plass K; Rodríguez O; Henríquez JDS; Hernández V; de la Peña E; Alemany I; Turturica D; Pisano F; Soria F; Čapoun O; Bauerová L; Pešl M; Bruins HM; Runneboom W; Herdegen S; Breyer J; Brisuda A; Scavarda-Lamberti A; Calatrava A; Rubio-Briones J; Seles M; Mannweiler S; Bosschieter J; Kusuma VRM; Ashabere D; Huebner N; Cotte J; Mertens LS; Cohen D; Lunelli L; Cussenot O; Sheikh SE; Volanis D; Coté JF; Rouprêt M; Haitel A; Shariat SF; Mostafid AH; Nieuwenhuijzen JA; Zigeuner R; Dominguez-Escrig JL; Hacek J; Zlotta AR; Burger M; Evert M; Hulsbergen-van de Kaa CA; van der Heijden AG; Kiemeney LALM; Soukup V; Molinaro L; Gontero P; Llorente C; Algaba F; Palou J; N'Dow J; Babjuk M; van der Kwast TH; Sylvester RJ
    Urol Oncol; 2020 May; 38(5):440-448. PubMed ID: 31704141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival.
    Jimenez RE; Gheiler E; Oskanian P; Tiguert R; Sakr W; Wood DP; Pontes JE; Grignon DJ
    Am J Surg Pathol; 2000 Jul; 24(7):980-7. PubMed ID: 10895820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Snail immunohistochemical overexpression correlates to recurrence risk in non-muscle invasive bladder cancer: results from a longitudinal cohort study.
    Santi R; Cai T; Nobili S; Galli IC; Amorosi A; Comperat E; Nesi G
    Virchows Arch; 2018 Apr; 472(4):605-613. PubMed ID: 29525824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival following the diagnosis of noninvasive bladder cancer: WHO/International Society of Urological Pathology versus WHO classification systems.
    Schned AR; Andrew AS; Marsit CJ; Zens MS; Kelsey KT; Karagas MR
    J Urol; 2007 Oct; 178(4 Pt 1):1196-200; discussion 1200. PubMed ID: 17698105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non-muscle-invasive bladder cancer.
    van de Putte EEF; Bosschieter J; van der Kwast TH; Bertz S; Denzinger S; Manach Q; Compérat EM; Boormans JL; Jewett MAS; Stoehr R; van Leenders GJLH; Nieuwenhuijzen JA; Zlotta AR; Hendricksen K; Rouprêt M; Otto W; Burger M; Hartmann A; van Rhijn BWG
    BJU Int; 2018 Dec; 122(6):978-985. PubMed ID: 29637669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival.
    Li G; Yu J; Song H; Zhu S; Sun L; Shang Z; Niu Y
    BMC Cancer; 2017 Aug; 17(1):530. PubMed ID: 28789622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of WHO 1973, WHO/ISUP 1998, WHO 1999 grade and combined scoring systems in evaluation of bladder carcinoma.
    Bircan S; Candir O; Serel TA
    Urol Int; 2004; 73(3):201-8. PubMed ID: 15539837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of vascular and perineural invasion in urothelial bladder cancer treated with radical cystectomy.
    Leissner J; Koeppen C; Wolf HK
    J Urol; 2003 Mar; 169(3):955-60. PubMed ID: 12576821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
    Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y
    Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic features and prognostic significance of mixed (Low and high-grade) papillary urothelial carcinoma comparison with low and high-grade papillary urothelial carcinoma.
    Kir G; Cecikoglu GE; Topal CS; Sorkun MH; Culpan M; Suceken FY; Karaca H; Yildirim A
    Virchows Arch; 2023 Nov; 483(5):621-634. PubMed ID: 37632533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.